InsiderTrades.com logo
Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis
From Weiss Ratings   |   Ad
Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …
Find out details on these three critical Nvidia partners immediately.

OBIO Insider Trading

Insider Ownership Percentage: 6.70%
Insider Buying (Last 12 Months): $91,205.00
Insider Selling (Last 12 Months): $138,572.97

Orchestra BioMed Insider Trading History Chart

This chart shows the insider buying and selling history at Orchestra BioMed by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Orchestra BioMed Share Price & Price History

Current Price: $4.92
Price Change: ▲ Price Increase of +0.12 (2.50%)
As of 12/20/2024 06:16 PM ET

This chart shows the closing price history over time for OBIO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
This Crypto Is Set to Explode in December
From Crypto 101 Media   |   Ad
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…
YES, I WANT THE #1 CRYPTO NOW

Orchestra BioMed Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/19/2024Andrew Lawrence TaylorCFOBuy1,000$4.83$4,830.00344,960View SEC Filing Icon  
12/18/2024David P HochmanInsiderBuy5,000$4.91$24,550.00575,498View SEC Filing Icon  
9/24/2024David P HochmanInsiderBuy2,500$4.91$12,275.00570,498View SEC Filing Icon  
9/9/2024Darren ShermanInsiderSell6,804$5.48$37,285.92772,691View SEC Filing Icon  
9/9/2024Eric S FainDirectorSell1,800$5.43$9,774.0043,010View SEC Filing Icon  
9/6/2024Darren ShermanInsiderSell6,819$5.65$38,527.35779,495View SEC Filing Icon  
9/6/2024Eric S FainDirectorSell2,000$5.64$11,280.0044,810View SEC Filing Icon  
9/4/2024Darren ShermanInsiderSell6,837$6.10$41,705.70793,275View SEC Filing Icon  
8/14/2024David P HochmanInsiderBuy2,500$5.84$14,600.00567,998View SEC Filing Icon  
6/25/2024David P HochmanInsiderBuy1,000$6.95$6,950.00333,502View SEC Filing Icon  
5/30/2024William Reed LittleInsiderBuy4,000$7.00$28,000.00307,859View SEC Filing Icon  
See Full Table
Amazon coin set to soar 25X – starting December 16th?
From True Market Insiders   |   Ad
This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team of crypto experts has identified it as the most promising crypto of 2024. You can see all of the details surrounding the #1 Crypto of 2024
>3-Cent Amazon Coin<

SEC Filings (Institutional Ownership Changes) for Orchestra BioMed (NASDAQ:OBIO)

53.55% of Orchestra BioMed stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at OBIO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Orchestra BioMed Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/21/2024SkyView Investment Advisors LLC12,284$63K0.0%-38.6%0.032%Search for SEC Filing on Google Icon
11/19/2024Barclays PLC31,785$0.16M0.0%+281.3%0.084%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC567,219$2.92M0.0%+2.0%1.492%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC31,785$0.16M0.0%+281.3%0.084%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC19,070$98K0.0%-19.8%0.050%Search for SEC Filing on Google Icon
11/15/2024State Street Corp429,613$2.21M0.0%+12.4%1.130%Search for SEC Filing on Google Icon
11/15/2024RTW Investments LP8,206,159$42.18M0.6%+46.0%21.587%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company33,305$0.17M0.0%-20.9%0.088%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.217,008$1.12M0.0%+3.9%0.574%Search for SEC Filing on Google Icon
11/1/2024ABLE Financial Group LLC13,402$69K0.0%N/A0.035%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC10,143$52K0.0%N/A0.028%Search for SEC Filing on Google Icon
8/16/2024SkyView Investment Advisors LLC20,000$0.16M0.0%N/A0.056%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company42,082$0.34M0.0%+8.4%0.118%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers26,439$0.22M0.0%+192.7%0.074%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp70,682$0.58M0.0%+115.7%0.197%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD571,075$3.01M0.0%-8.3%1.596%Search for SEC Filing on Google Icon
5/11/2024Catalytic Wealth RIA LLC22,261$0.12M0.0%N/A0.062%Search for SEC Filing on Google Icon
2/1/2024New York State Common Retirement Fund3,623$33K0.0%-68.6%0.010%Search for SEC Filing on Google Icon
10/27/2023Allspring Global Investments Holdings LLC4,904$43K0.0%N/A0.014%Search for SEC Filing on Google Icon
10/27/2023TD Asset Management Inc92,678$0.81M0.0%+100.0%0.259%Search for SEC Filing on Google Icon
10/24/2023Bank of New York Mellon Corp40,290$0.35M0.0%+211.2%0.113%Search for SEC Filing on Google Icon
10/18/2023UMB Bank n.a.3,160$28K0.0%N/A0.009%Search for SEC Filing on Google Icon
10/13/2023Arkadios Wealth Advisors51,595$0.45M0.0%N/A0.144%Search for SEC Filing on Google Icon
8/24/2023Perceptive Advisors LLC2,052,868$14.37M0.4%-9.9%5.744%Search for SEC Filing on Google Icon
8/11/2023Atika Capital Management LLC64,651$0.45M0.0%N/A0.181%Search for SEC Filing on Google Icon
5/16/2023Boxer Capital LLC250,000$4.89M0.2%N/A2.230%Search for SEC Filing on Google Icon
5/15/2023RTW Investments LP5,118,507$100.17M2.1%N/A45.652%Search for SEC Filing on Google Icon
4/18/2023IFP Advisors Inc2,980$34K0.0%N/A0.027%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Orchestra BioMed logo
Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold devices and minimally invasive surgery devices. The company has a collaboration agreement with Medtronic, Inc. for the development and commercialization of BackBeat CNT for the treatment of HTN in patients indicated for a cardiac pacemaker; and a strategic collaboration with Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.
Read More on Orchestra BioMed

Today's Range

Now: $4.92
Low: $4.49
High: $4.98

50 Day Range

MA: $5.56
Low: $4.76
High: $6.36

52 Week Range

Now: $4.92
Low: $4.22
High: $10.44

Volume

191,268 shs

Average Volume

74,889 shs

Market Capitalization

$187.03 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.44

Who are the company insiders with the largest holdings of Orchestra BioMed?

Orchestra BioMed's top insider investors include:
  1. Darren Sherman (Insider)
  2. David P Hochman (Insider)
  3. Andrew Lawrence Taylor (CFO)
  4. William Reed Little (Insider)
  5. Eric S Fain (Director)
Learn More about top insider investors at Orchestra BioMed.

Who are the major institutional investors of Orchestra BioMed?

Orchestra BioMed's top institutional investors include:
  1. RTW Investments LP — 21.59%
  2. Geode Capital Management LLC — 1.49%
  3. State Street Corp — 1.13%
  4. Charles Schwab Investment Management Inc. — 0.57%
  5. The Manufacturers Life Insurance Company — 0.09%
  6. Barclays PLC — 0.08%
Learn More about top institutional investors of Orchestra BioMed stock.

Which major investors are selling Orchestra BioMed stock?

During the previous quarter, OBIO stock was sold by these institutional investors:
  1. The Manufacturers Life Insurance Company
  2. SkyView Investment Advisors LLC
  3. Jane Street Group LLC
Within the previous year, company insiders that have sold Orchestra BioMed company stock include:
  1. Darren Sherman (Insider)
  2. David P Hochman (Insider)
Learn More investors selling Orchestra BioMed stock.

Which major investors are buying Orchestra BioMed stock?

In the previous quarter, OBIO stock was bought by institutional investors including:
  1. RTW Investments LP
  2. State Street Corp
  3. Barclays PLC
  4. Barclays PLC
  5. ABLE Financial Group LLC
  6. Geode Capital Management LLC
  7. SG Americas Securities LLC
  8. Charles Schwab Investment Management Inc.
In the last year, these company insiders have bought Orchestra BioMed stock:
  1. Darren Sherman (Insider)
  2. David P Hochman (Insider)
  3. Andrew Lawrence Taylor (CFO)
Learn More investors buying Orchestra BioMed stock.
Missed Nvidia? Buy Elon Musk’s “Silent Partner”
From Brownstone Research   |   Ad
In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner.
So please click here to see the details because a lot of people could get rich.